PAREXEL INTERNATIONAL TO PRESENT AT UBS GLOBAL HEALTHCARE SERVICES CONFERENCE
BOSTON, MA, February 10, 2005 — PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the UBS Global Healthcare Services Conference at The Plaza Hotel in New York City. Josef von Rickenbach, Chairman and Chief Executive Officer, and James Winschel, Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at 3:00 p.m. ET on Monday, February 14th.
A live webcast of this presentation will be available on the UBS website located at www.ibb.ubs.com. Click on the Conference link in the middle of the page and then follow the link for Webcast under the Global Healthcare Services Conference heading. After the conference, the webcast will be archived and available on this site for 30 days.
PAREXEL is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales. The technology portfolio includes web-based portal solutions and tracking tools, Interactive Voice Response Systems (IVRS), Clinical Trial Management Systems (CTMS), electronic diary and investigator database solutions. Perceptive also offers advanced medical diagnostics services to assess rapidly and objectively the safety and efficacy of new drugs, biologics, and medical devices in clinical trials. PAREXEL’s integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 51 locations throughout 36 countries around the world, and has 4,935 employees.
PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective owners and are hereby acknowledged.